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    Human Herpes Virus 8 (HHV8) causes Kaposi’s sarcoma, a common cancer among AIDS patients. It is 
proposed that this virus plays a role in formation of some blood vessel and lymphoma tumors. This study 
aimed to investigate the frequency of KSHV among benign and malignant breast tumors. A total of 24 
carcinomas and 24 fibroadenomas paraffin embedded tumoral tissue samples were obtained from the 
pathology sections of Toos and Firoozgar hospitals in Tehran, Iran. All samples had been collected from 
patients during a period of time effective from June 2013 to February 2014. DNA was extracted from all 
samples and their infection with HHV8 was examined by PCR technique. The results obtained by this 
study showed that 6 out of 24 carcinoma samples (25%) were infected by KSHV, while the number of 
fibroadenoma samples infected by this virus was 9 (37.5%). The frequency of HHV8 infection was 
different among malignant and benign tumors. Based on the results obtained by this study, KSHV was 
observed in both benign and malignant tumors. Since KSHV was observed in both types of tumors 
therefore, it may not have significant relationship with tumor type. The role of KSHV in vessel tumors has 
been proved by many studies during the past decade. Some other studies have also defined a role for this 
virus in formation of breast fibroadenoma tumor. Therefore, further studies are needed to define the 
influence of this virus in breast tumors formation. 
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INTRODUCTION 
     Breast cancer is the uncontrolled growth of 
abnormal cells, which is created in various 
regions of the breast. This cancer may develop in 
different tissues such as ducts, which transfer 
breast milk, production tissue of the milk, and in 
unglandular tissue. Breast cancer is the most 
prevalent cancer in women [1]. Every year, a 
large number of women are afflicted by breast 
cancer, of which the disease is fatal for a number 
of sufferers [2]. According to the data presented 
by the US National Institute of Cancer, one out 
of every 8 women will be inflicted with breast 
cancer [3]. Although genetic factors such as 
mutation in the BRCA1 and BRCA 2 genes play 
an important role in occurrence of breast cancer 
[4-5],however, other susceptible factors cannot 
be neglected. For instance, the risk of suffering 
from breast cancer increases with age [6-7]. 
Almost, three quarters of the cases of affliction 
occur in women who are over 50 years old. 
Except for age, other risk factors include family 
history of breast cancer, puberty before the age 
of 13, menopause after the age of 51, women 
who have never become pregnant and those who 
have had the first pregnancy after 30, obesity 
particularly after menopause, poor diet [8], 
alcohol consumption, and viral infection [5]. 
The studies carried out in two recent decades 
have provided evidences for the role of viruses 
in the occurrence of breast cancer[9-
14].Kaposi’s sarcoma-associated herpes virus 
(KSHV) belongs to the gamma herpesvirus 
family and is the causative agent of various 
lymphoproliferative diseases in humans [15]. It 
was later shown that this virus causes Kaposi’s 
sarcoma, which is a common cancer among 
AIDS patients.It is proposed that KSHV plays a 
role in formation of some blood vessel and 
lymphoma tumors. Attributes of this virus have a 
double strand DNA and icosahedral 
symmetry[16]. The nocleocapsid is surrounded 
 




by a covering being of the lipid genus type [17]. 
Amplification of a small fragment of KSHV 
genome is the most common technique for 
detection of this virus in clinical samples 
[18].This study aimed to investigate the 
frequency of KSHV among females with benign 
and malignant breast tumors. 
 
MATERIALS AND METHODS  
Demographic data of patients 
    The number of patients who suffered from 
carcinoma based on age groups included 5 
patients (21%) below 35 years, 12 patients 
(50%) at 35-55 years, and 7 patients (29%) over 
55 years old. The average tumor size in 6 
patients (25%) was smaller than 2 cm, while in 
18 patients (75%) the average tumor size was 
larger than 2 cm. 
Regarding the lymphatic glands involvement, 18 
patients (75%) showed involvement, while the 
rest 6 patients (25%) had no involvement. 
Among the studied carcinoma samples, the 
number of patients with ductal, lobular, and 
mucinous carcinomas were 22 (92%), 1 (4%) 
and 1 (4%), respectively. Four patients (16.6%) 
suffered from stage I malignant tumor, 9 (37.5%) 
had reached stage II, and 11 (45.9%) were at 
stage III (Table 1).  
As to demographic data of patients with 
fibroadenoma, only ages of the individuals were 
available, of which 17 (71%) were under 35 
years old and 7 (29%) between 35-55 years old. 
Sample collection 
    Paraffin embedded samples of the breast 
carcinoma (N=24) and fibroadenoma (N=24) 
were collected from the pathology departments 
of Toos and Firozgar hospitals located in Tehran, 
Iran. The samples had been stored during a 
period of time effective from June2013 until 
February 2014. The carcinogenicity of the 
samples was diagnosed based on the Richardson 
classification systemby an experienced 
pathologist. 
Deparaffinization of the samples 
    Paraffin embedded sample blocks were cut 
in5µ slides by sterile microtome blade (N35). 
The sample slides were kept into sterile 
containers until deparaffinization. To 
deparaffinize, the samples were left in a xylene 
solution (Merck Germany) for 30 minutes 
followed bysoakingin respectively 100%, 80%, 
60%, and 40% ethanol (Merck Germany), each 
for 10 s. The tissue obtained was then transferred 




DNA extraction  
    DNA extraction was carried out by kit 
according to the manufacturer instruction 
(Qiagene, Lot No: 11872534, Cat No: 51306). 
The purity of extracted DNAs was analyzed 
based on their absorbance at 260 and 280 nm 
wavelengths by biophotometer (Eppendorf, 
Germany).  
Human beta-globin gene amplification 
    Human beta-globin gene was co-amplified 
with the target fragment, as an internal 





Each reaction was performed in a total volume 
of 25 µl containing 14 µl of molecular biology-
grade water (Sigma Aldrich Company LTD., 
USA), 2.5 µl of 10×PCR buffer (Promega, 
USA), 1 µl of 10 pmol of forward and reverse 
PCR primers, 1 µl of 10 mM dNTPs (Promega, 
USA), 0.5 µl of smart taq DNA polymerase 
(Promega, USA), 1 µl of 50 mM MgCl2 
(Promega, USA) and 5 µl of DNA template. The 
negative control tube contained the same PCR 
reagents as above but had 5 µl of water 
substituted for the DNA template.  
PCR amplification conditions on thermocycler 
(Biorad-Germany) were as follows: 94°C for 5 
min, followed by 35 cycles of 94°C for 50 s, 
54°C for 45 s and 72°C for 40 s, with a final 
extension at 72°C for 5 min.  
HHV8 gene (ORF 26) amplification 
    Specific Primers produced by TAG 
Copenhagen (Denmark) were used to amplify the 
KSHV gene. The sequences of forward and 
reverse primers were 5'-
CTCGAATCCAACGGATTTGA-3' and 5'- 
ATATGTGCGCCCCATAAATG -3', 
respectively [19]. Each reaction was performed 
as mentioned former for standard gene.PCR 
amplification conditions on thermocycler 
(Biorad-Germany) were as follows: 95°C for 5 
min, followed by 35 cycles of 95°C for 50 s, 
 




54.5°C for 50 s and 72°C for 50 s, with a final 
extension at 72°C for 5 min. 
Electrophoresis 
    An aliquot of all PCR products was run on a 
1.5% (w/v) agarose gels with a 100 bp DNA 
ladder (Fermntas-Russia) and electrophoresed at 
75 V for 40 min. The bands were visualized 
using ethidium bromide staining and 
photographed after UV treatment by a 
transilluminator (UV doc, England). 
Statistical analysis 
    Chi square test was used to determine whether 
there was any significant difference between the 
frequency of KSHV in the carcinoma and 
fibroadenoma samples and its relationship with 
the breast cancer (SPSS software 19). 
 
RESULTS 
    In order to identify the DNA of virus in the 
tissue samples, the PCR technique was used. The 
amplified fragments of human beta-globin gene 
and viral DNA were 122 bp and 233 bp, 
respectively.Some examples of beta globin gene 
andKSHV amplification productselectrophoresed 
on 1.5% agarose gels are given in Figures 1 and 
2. 
 
Table 1. Distribution of KSHV by demographic variables in patients who suffered from carcinoma 
Demographic variable Status No. Tested No. KSHV+ No. KSHV- 
Age (years) < 35 5 0 5 
35-55 12 3 9 
> 55 7 3 4 
tumor size smaller than 2 cm 6 2 4 
larger than 2 cm 18 4 14 
lymphatic glands involvement yes 18 3 15 
No 6 3 3 
Type of carcinoma ductal 22 6 16 
lobular 1 0 1 
mucinous 1 0 1 
Stage of tumor I 4 1 3 
II 9 2 7 
III 11 3 8 
Total  24 6 18 
 
 
Figure 1. Beta globin gene amplification products 
electrophoresedon a 1.5% agarose gel. Lane M: 100 bp 
molecular marker; lane 1 and 2:Human beta-globin gene; 
lane 3:Negative control 
 
 
Figure 2. KSHV amplification products electrophorased 
on a 1.5% agarose gel. Lane M: 100 bp molecular marker; 
lane 1:Positive control; lane 2 and 3:Viral DNA (+); lane 
4:Viral DNA (-); lane 4 Negative control. 
 
 




Regarding the infection with KSHV, the PCR 
amplification was positive for 6patients with 
carcinoma (25%), of which 3 were at the age 
group of 35-55 years, and the other 3 were over 
55 years old. All6 patients infected with the 
virus were suffering from ductal carcinoma that 
3 of them (50%) had lymph node involvement. 
As to the tumor size, 4 samples were larger than 
2 cm in diameter, while 2 samples were below 2 
cm. Of all patients infected with virus, 3were at 
stage III,2 in stage II, and 1 in stage I. Out of 24 
samples of fibroadenoma, 9 (37.5%) were 
detected to be infected with KSHV.Among 9 
patients, 7were below 35 years old, while 2were 
at the group of 35-55 years. The statistical 
analysis showed no significant relationship 




    KHSV is not considered as a common virus as 
compared to all other herpes viruses. However, 
serological tests have shown that 5%-10% of 
Americans are infected by HHV8. It is proposed 
that this virus can be transmitted through sexual 
contact between homosexual men, as a high level 
of infection (37%) is observed among them. The 
infection is more common in Africa (30%-60%), 
where the virus is transmitted non-sexually at the 
early stages of life. KSHV is detectable in saliva 
and can be transmitted through kidney 
transplantation too. During the past decade, it has 
also been confirmed that this virus plays a role in 
formation of some types of tumors[20]. KSHV 
tumorigenic property is attributed to the 
production of different cytokines such as 
interleukin 6 (IL6).  
A high level of IL6 has been found to be 
associated with some types of cancers such as 
prostate [24], ovarian[25], and lymphomas [26]. 
Moreover, some other studies[27-30]have shown 
an association between higher levels of IL6 and 
tumor development as well as metastasis in breast 
carcinoma.As well as Kaposi’s sarcoma herpes-
virusencoded Small noncoding RNAs (miRNAs) 
may promote cancer pathogenesis. Burgeoning 
evidence suggests that dysregulation of miRNAs 
may promote cancer pathogenesis [21-23]. 
The current research that was conducted to 
determine the frequency of KSHV on the benign 
and malignant tumor, led to the identification of 
this virus in both types of tumors with a 
prevalence of 25% and 37.5% in ductal carcinoma 
and fibroadenoma, respectively.There was no 
significant relationship between the KSHV and 
tumor type, size and stage as well as age of 
patients. This might be due to the small sample 
size. Therefore further investigation in a larger 
cohort is necessary. Opposite to the results 
obtained by this study, some studies have 
confirmed an association between KSHV and 
breast fibroadenoma. Newton and his colleagues 
suggested a relationship between KSHV and 
breast cancer using immunoserology tests [20]. 
Also, Hsu and colleagues reported a significant 
association between this virus and breast cancer 
using PCR and Sothern blotting techniques [14]. 
Although these results indicate a correlation 
between KSHV and breast cancer, however, the 
molecular events underlying the role of this virus 
in formation of breast tumors have not been 
defined so far. 
 
CONCLUSION 
     The results obtained by this study showed the 
presence of KSHV in both malignant and benign 
tumors of breast.  
Although these results do not support the 
hypothesis that there is a relationship between 
KSHV infection and breast cancerbecause it is a 
pilot study and validation is necessary in a large 
cohort.However, further studies are needed to 
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